At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Ringer's Lactate Crystalloid Solutionsdrug
Likely dose
Ringer's Lactate Crystalloid Solutions 7 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessing Fluid Intolerance Using Portal Vein Pulsatility Index Post-Passive Leg Raising Test in Fluid Responders: A Prospective Cohort Study
Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu·observational·Posted Jun 4, 2024·Updated Aug 27, 2024
In Brief
An observational study evaluating Ringer's Lactate Crystalloid Solutions for Venous Congestion. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study uses the portal vein pulsatility index (PVPI) to assess fluid intolerance amongst fluid responders.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Congestion
CountriesRomania
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMay 2023
First PostedJun 2024
Primary CompletionJul 2024
TodayJul 2026
First PostedJun 4, 2024
Enrollment StartMay 1, 2023
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 2.1 years ago
Interventions
Ringer's Lactate Crystalloid Solutionsdrug
7 ml/kg ml of Ringer's Lactate is given in 10 min amongst initially tolerant fluid responders.